Related Experiment Videos
Behavior and treatment in frontotemporal dementia
1Memory and Aging Center, University of California at San Francisco, USA.
Neurology
|June 13, 2001
Summary
Frontotemporal dementia commonly presents with behavioral syndromes. This review covers these changes and discusses pharmacological treatments for managing frontotemporal dementia symptoms.
Area of Science:
- Neuroscience
- Clinical Neurology
- Behavioral Science
Background:
- Behavioral syndromes are a hallmark of frontotemporal dementia (FTD).
- Understanding these behavioral changes is crucial for diagnosis and management.
- Existing literature highlights the need for comprehensive reviews of FTD-related behaviors.
Purpose of the Study:
- To review the spectrum of behavioral syndromes observed in frontotemporal dementia.
- To describe current pharmacologic interventions targeting these behavioral syndromes.
- To provide a clinical overview for healthcare professionals managing FTD.
Main Methods:
- Literature review of studies on frontotemporal dementia and behavioral changes.
- Synthesis of clinical findings related to FTD behavioral syndromes.
- Analysis of pharmacologic treatments reported for FTD behavioral symptoms.
Main Results:
- Detailed description of common behavioral syndromes in FTD, including apathy, disinhibition, and repetitive behaviors.
- Overview of pharmacologic agents and their efficacy in managing specific FTD behavioral symptoms.
- Discussion of treatment challenges and future directions.
Conclusions:
- Behavioral syndromes are key diagnostic features of frontotemporal dementia.
- Pharmacologic interventions offer potential for managing FTD-related behavioral disturbances.
- Further research is needed to optimize treatment strategies for FTD behavioral symptoms.